Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
EBIATLong-Term Debt IssuancesReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Ares Capital (ARCC) Shares Issued (2021 - 2025)

Ares Capital has reported Shares Issued over the past 5 years, most recently at $22.0 million for Q4 2025.

  • Quarterly Shares Issued fell 95.83% to $22.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $544.0 million through Mar 2026, down 67.29% year-over-year, with the annual reading at $928.0 million for FY2025, 31.96% down from the prior year.
  • Shares Issued was $22.0 million for Q4 2025 at Ares Capital, down from $204.0 million in the prior quarter.
  • Over five years, Shares Issued peaked at $528.0 million in Q4 2024 and troughed at $22.0 million in Q4 2025.
  • The 5-year median for Shares Issued is $229.0 million (2022), against an average of $269.4 million.
  • The largest YoY upside for Shares Issued was 351.76% in 2025 against a maximum downside of 95.83% in 2025.
  • A 5-year view of Shares Issued shows it stood at $132.0 million in 2021, then soared by 46.21% to $193.0 million in 2022, then increased by 22.28% to $236.0 million in 2023, then soared by 123.73% to $528.0 million in 2024, then plummeted by 95.83% to $22.0 million in 2025.
  • Per Business Quant, the three most recent readings for ARCC's Shares Issued are $22.0 million (Q4 2025), $204.0 million (Q3 2025), and $318.0 million (Q2 2025).